Q BioMed Inc. Share Price Other OTC
Equities
QBIO
US74736N1054
Biotechnology & Medical Research
Sales 2021 | 0.2 15.48 | Sales 2022 | 0.28 22.5 | Capitalization | 1.35M 107M |
---|---|---|---|---|---|
Net income 2021 | -8M -633M | Net income 2022 | -2M -158M | EV / Sales 2021 | 79,967,019 x |
Net Debt 2021 | 2.71M 214M | Net Debt 2022 | 4.06M 321M | EV / Sales 2022 | 19,023,098 x |
P/E ratio 2021 |
-1.39
x | P/E ratio 2022 |
-0.2
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 97.01% |
Managers | Title | Age | Since |
---|---|---|---|
Denis Corin
CEO | Chief Executive Officer | 51 | 20/04/15 |
Ari Jatwes
DFI | Director of Finance/CFO | - | - |
Director/Board Member | 55 | 31/05/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 55 | 31/05/15 | |
Denis Corin
CEO | Chief Executive Officer | 51 | 20/04/15 |
Rick Panicucci
BRD | Director/Board Member | 63 | 12/02/18 |
1st Jan change | Capi. | |
---|---|---|
+16.13% | 122B | |
+19.65% | 113B | |
+20.73% | 26.49B | |
-23.84% | 19.4B | |
-17.80% | 16.24B | |
-45.95% | 15.15B | |
-19.28% | 15.4B | |
+63.81% | 14.93B | |
+1.94% | 13.52B |